Newsroom | 5182 results

BASEL, Schweiz--(BUSINESS WIRE)--Ascensia Diabetes Care, ein weltweit tätiges Unternehmen im Bereich Diabetesversorgung und Tochtergesellschaft der PHC Holdings Corporation (TSE 6523), gab heute die Markteinführung der CONTOUR®COMFORT Pen-Nadeln bekannt und stärkt damit sein CONTOUR® Portfolio um eine Lösung, die das tägliche Injektionserlebnis verbessert. „Mit den CONTOUR COMFORT Pen-Nadeln unterstützen wir Menschen mit Diabetes bei einem wichtigen Bestandteil ihres täglichen Diabetesmanagemen...

BOSTON & SHANGHAI--(BUSINESS WIRE)--Multiple Clinical Trial Data for Elecoglipron (AZD5004/ECC5004), an Oral GLP-1 Receptor Agonist, to be Presented at ADA 2026...

BASEL, Switzerland--(BUSINESS WIRE)--Ascensia Diabetes Care, a global diabetes care company and subsidiary of PHC Holdings Corporation (TSE 6523), today announced the launch of CONTOUR®COMFORT pen needles, further strengthening its CONTOUR® portfolio with a solution that improves the everyday injection experience. “With CONTOUR COMFORT pen needles, we are addressing a very practical and important part of diabetes management,” said Peter Bodlund, President and Chief Executive Officer of Ascensia...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that new data from its obesity portfolio will be presented at the 2026 Scientific Sessions of the American Diabetes Association® (ADA). The insights demonstrate significant progress in addressing a range of unmet needs for people living with obesity or overweight such as long-term treatment adherence, which could be supported by a favorable safety and tolerability p...

SAN FRANCISCO--(BUSINESS WIRE)--Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced the expansion of Hims & Hers Benefits, adding eight new partners to the Hims & Hers exclusive program. Joining founding partners Prenuvo and Eight Sleep are Natural Cycles, MyFitnessPal, Ladder, PVOLVE Studios, HelloFresh, Factor, Flo Health, Dexcom, and iFIT - a carefully curated lineup spanning nutrition, fitness, women's health, metabolic monitoring, an...

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Wednesday, June 3, 2026 at 2:00 p.m. (Central Time). The live webcast and replay of the presentation will be accessible on the Insulet Investor Relations website: investors.insulet.com/events. About Insulet Corporation: Insul...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Hepta, a liquid biopsy company developing blood tests for chronic disease, today announced clinical data showing its blood test more accurately identifies metabolic dysfunction-associated steatohepatitis (MASH) patients eligible for treatment than the three non-invasive tests recommended by current clinical guidelines: FIB-4, ELF, and FibroScan. The 528-patient, multi-cohort study will be presented at the European Association for the Study of the Liver (EAS...

PALO ALTO, Calif.--(BUSINESS WIRE)--Signos Inc., the company behind the first FDA-cleared, over-the-counter glucose monitoring system for weight management, today announced a $20 million funding round with investment from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. As part of the partnership with Dexcom, Signos will be available for purchase on Stelo.com, Dexcom's direct-to-consumer CGM website, making it easier for people to find and access the Signos system. Signos ha...

SAN FRANCISCO--(BUSINESS WIRE)--Junevity to Present Breakthrough Research on siRNA Therapeutics at American Aging Association’s 2026 Annual Meeting...

PALO ALTO, Calif.--(BUSINESS WIRE)--Tidepool+ Direct Connect launches in Epic Showroom, bringing diabetes device data into clinician workflows with one click....